Login to Your Account

Arena Raising $35.5M in Stock Sale to Deerfield as PDUFA Date Looms

By Catherine Hollingsworth

Friday, June 4, 2010
Arena Pharmaceuticals Inc. has agreed to sell shares to Deerfield Management for $35.5 million, money that will bolster the biotech's cash as it seeks FDA approval of its obesity compound lorcaserin. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription